litlas
ログインアカウント作成

Rafael Rosell

1994–2025 年に発表

245
論文数
62,327
被引用数
119
h 指数
239
i10 指数

被引用数

Rafael Rosell の年別被引用数1963 年: 被引用 1 件1971 年: 被引用 5 件1990 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 4 件1996 年: 被引用 3 件1997 年: 被引用 4 件1998 年: 被引用 9 件1999 年: 被引用 32 件2000 年: 被引用 57 件2001 年: 被引用 94 件2002 年: 被引用 100 件2003 年: 被引用 114 件2004 年: 被引用 192 件2005 年: 被引用 273 件2006 年: 被引用 276 件2007 年: 被引用 312 件2008 年: 被引用 218 件2009 年: 被引用 310 件2010 年: 被引用 341 件2011 年: 被引用 342 件2012 年: 被引用 370 件2013 年: 被引用 555 件2014 年: 被引用 447 件2015 年: 被引用 553 件2016 年: 被引用 559 件2017 年: 被引用 549 件2018 年: 被引用 626 件2019 年: 被引用 2,043 件2020 年: 被引用 2,187 件2021 年: 被引用 2,254 件2022 年: 被引用 1,702 件2023 年: 被引用 1,293 件2024 年: 被引用 1,839 件2025 年: 被引用 793 件2026 年: 被引用 27 件1964〜1970 年は被引用が無いため表示していません1972〜1989 年は被引用が無いため表示していません1991〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,086 件、この内訳の 22.9%中国: 引用元論文 3,685 件、この内訳の 16.6%イタリア: 引用元論文 1,206 件、この内訳の 5.4%日本: 引用元論文 1,110 件、この内訳の 5%イギリス: 引用元論文 986 件、この内訳の 4.4%スペイン: 引用元論文 921 件、この内訳の 4.2%フランス: 引用元論文 904 件、この内訳の 4.1%ドイツ: 引用元論文 869 件、この内訳の 3.9%韓国: 引用元論文 667 件、この内訳の 3%カナダ: 引用元論文 647 件、この内訳の 2.9%オランダ: 引用元論文 533 件、この内訳の 2.4%オーストラリア: 引用元論文 447 件、この内訳の 2%
0%22.9%その他 23.2%

機関

分野

  • Medicine63.9%
  • Biochemistry, Genetics and Molecular Biology28.8%
  • Immunology and Microbiology3.1%
  • Computer Science0.8%
  • Chemistry0.7%
  • Engineering0.6%
  • その他2.1%

トピック

  • Lung Cancer Treatments and Mutations14.1%
  • Lung Cancer Diagnosis and Treatment7%
  • Lung Cancer Research Studies6.2%
  • Cancer Immunotherapy and Biomarkers5%
  • Cancer Genomics and Diagnostics4.4%
  • Colorectal Cancer Treatments and Studies1.9%
  • その他61.4%

共著者

全論文

検索で開く
  1. Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

    著者: J. Mazieres, Alexander Drilon, Amélie Lusque, Laurent Mhanna, Alexis B. Cortot, Laura Mezquita, Alesha A. Thai, Céline Mascaux, S. Couraud, Rémi Veillon, Michel M. van den Heuvel, Joel W. Neal, Nir Peled, Martin Früh, Terry L. Ng, V. Gounant, Sanjay Popat, Joachim Diebold, Joshua K. Sabari, Viola W. Zhu, Sacha I. Rothschild, Paolo Bironzo, Alex Martínez‐Martí, Alessandra Curioni‐Fontecedro, Rafael Rosell, Mickaël Lattuca-Truc, Marcel Wiesweg, Benjamin Besse, Benjamin Solomon, Fabrice Barlési, Robert D. Schouten, Heather A. Wakelee, D. Ross Camidge, Gérard Zalcman, Silvia Novello, Sai‐Hong Ignatius Ou, Julie Milia, Oliver Gautschi - Annals of Oncology 2019 被引用: 1,361

  2. Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

    著者: Solange Peters, D. Ross Camidge, Alice T. Shaw, Shirish M. Gadgeel, Jin Seok Ahn, Dong‐Wan Kim, Sai‐Hong Ignatius Ou, M. Pérol, Rafał Dziadziuszko, Rafael Rosell, Ali Zeaiter, Emmanuel Mitry, Sophie Golding, Bogdana Balas, Johannes Noé, Peter N. Morcos, Tony Mok - New England Journal of Medicine 2017 被引用: 2,455

  3. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

    著者: Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares - The Lancet Oncology 2012 被引用: 5,530

  4. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    著者: William D. Travis, Élisabeth Brambilla, Masayuki Noguchi, Andrew G. Nicholson, Kim R. Geisinger, Yasushi Yatabe, David G. Beer, Charles A. Powell, Gregory J. Riely, Paul E. Van Schil, Kavita Garg, John H. M. Austin, Hisao Asamura, Valerie W. Rusch, Fred R. Hirsch, Giorgio V. Scagliotti, Tetsuya Mitsudomi, Rudolf M. Huber, Yuichi Ishikawa, James R. Jett, Montse Sánchez‐Céspedes, Jean‐Paul Sculier, Takashi Takahashi, Masahiro Tsuboi, Johan Vansteenkiste, Ignacio I. Wistuba, Pan‐Chyr Yang, Denise R. Aberle, Christian Brambilla, Douglas B. Flieder, Wilbur A. Franklin, Adi F. Gazdar, Michael K. Gould, P S Hasleton, Douglas W. Henderson, Bruce Johnson, David Johnson, Keith M. Kerr, Keiko Kuriyama, Jin Soo Lee, Vincent A. Miller, Iver Petersen, Victor L. Roggli, Rafael Rosell, Nagahiro Saijo, Erik Thunnissen, Ming‐Sound Tsao, David Yankelewitz - Journal of Thoracic Oncology 2011 被引用: 4,843

  5. Non-small-cell lung cancer

    著者: Cesare Gridelli, Antônio Rossi, David P. Carbone, Juliana Guarize, Niki Karachaliou, Tony Mok, Francesco Petrella, Lorenzo Spaggiari, Rafael Rosell - Nature Reviews Disease Primers 2015 被引用: 1,095

  6. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

    著者: Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti, Jean-Yves Douillard, Frances A. Shepherd, Richard Stephens, Ariane Dunant, Valter Torri, Rafael Rosell, Lesley Seymour, Stephen Spiro, Estelle Rolland, Roldano Fossati, D. Aubert, Keyue Ding, David Waller, Thierry Le Chevalier - Journal of Clinical Oncology 2008 被引用: 2,670

  7. Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial

    著者: Yi‐Long Wu, Ying Cheng, Xiangdong Zhou, Ki Hyeong Lee, Kazuhiko Nakagawa, Seiji Niho, Fumito Tsuji, R. Linke, Rafael Rosell, J. Corral, Maria Rita Migliorino, Adam Płużański, Eric Sbar, Tao Wang, Jane Liang White, Sashi Nadanaciva, Rickard Sandin, Tony Mok - The Lancet Oncology 2017 被引用: 1,210

  8. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study

    著者: Tony Mok, D. Ross Camidge, Shirish M. Gadgeel, Rafael Rosell, Rafał Dziadziuszko, D.-W. Kim, M. Pérol, S.-H.I. Ou, Jin Seok Ahn, A. Shaw, Walter Bordogna, Vlatka Smoljanović, Magalie Hilton, Thorsten Ruf, Johannes Noé, Solange Peters - Annals of Oncology 2020 被引用: 686

  9. Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

    著者: Rafael Rosell, Teresa Morán, Cristina Queralt, Rut Porta, Felipe Cardenal, Carlos Camps, Margarita Majem, Guillermo López-Vivanco, Dolores Isla, Mariano Provencio, Amelia Insa, Bartomeu Massutí, J.L. González-Larriba, Luis Paz‐Ares, Isabel Bover, Rosario García‐Campelo, Miguel Ángel Moreno, Sílvia Catot, Christian Rolfo, Noemı́ Reguart, Ramón Palmero, José Miguel Sánchez, Roman Bastus, Clara Mayo, Jordi Bertran-Alamillo, Miguel Ángel Molina‐Vila, José Javier Sánchez, Miquel Tarón - New England Journal of Medicine 2009 被引用: 2,377

  10. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

    著者: Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, Victor Olivas, Valerie Au, Thomas LaFramboise, Mohamed Abdel-Rahman, Xiaoqi Wang, Alan D. Levine, Jin Kyung Rho, Yun Jung Choi, Chang‐Min Choi, Sang-We Kim, Se Jin Jang, Young Soo Park, Woo Sung Kim, Dae Ho Lee, Jung‐Shin Lee, Vincent A. Miller, Maria E. Arcila, Marc Ladanyi, Philicia Moonsamy, Charles L. Sawyers, Titus J. Boggon, C. Patrick, Carlota Costa, Miquel Tarón, Rafael Rosell, Balázs Halmos, Trever G. Bivona - Nature Genetics 2012 被引用: 1,220

  11. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

    著者: Luping Lin, Amit J. Sabnis, Elton Chan, Victor Olivas, Lindsay Cade, Evangelos Pazarentzos, Saurabh Asthana, Dana S. Neel, Jenny Yan, Xinyuan Lu, Luu Pham, Mingxue M Wang, Niki Karachaliou, María González Cao, José Luís Manzano, José Luis Ramírez, J.M. Sanchez Torres, Fiamma Buttitta, Charles M. Rudin, Eric A. Collisson, Alain P. Algazi, Eric M. Robinson, Iman Osman, Eva Muñoz‐Couselo, Javier Cortés, Dennie T. Frederick, Zachary A. Cooper, Martin McMahon, Antonio Marchetti, Rafael Rosell, Keith T. Flaherty, Jennifer A. Wargo, Trever G. Bivona - Nature Genetics 2015 被引用: 553

  12. Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification

    著者: Brendan Bulik‐Sullivan, Jennifer Busby, Christine D. Palmer, Matthew J. Davis, Tyler Murphy, Andrew P. Clark, Michele Busby, Fujiko Duke, Aaron Yang, Lauren Young, Noelle C Ojo, Kamilah Caldwell, Jesse Abhyankar, Thomas Boucher, Meghan G. Hart, Vladimir Makarov, Vincent de Montpréville, Olaf Mercier, Timothy A. Chan, Giorgio V. Scagliotti, Paolo Bironzo, Silvia Novello, Niki Karachaliou, Rafael Rosell, Ian C. Anderson, Nashat Gabrail, John Hrom, Chainarong Limvarapuss, Karin Choquette, Alexander I. Spira, Raphaël F. Rousseau, Cynthia Voong, Naiyer A. Rizvi, Élie Fadel, Mark G. Frattini, Karin Jooss, Mojca Škoberne, Joshua M. Francis, Roman Yelensky - Nature Biotechnology 2018 被引用: 310

  13. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    著者: Nasser H. Hanna, Bryan J. Schneider, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Laurie E. Gaspar, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, Ishmael Jaiyesimi, David H. Johnson, Natasha B. Leighl, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Navneet Singh, David R. Spigel, Janis O. Stabler, Joan Tashbar, Gregory A. Masters - Journal of Clinical Oncology 2020 被引用: 455

  14. Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets

    著者: Myron G. Best, Nik Sol, Sjors G. J. G. In ‘t Veld, Adrienne Vancura, Mirte Muller, Anna-Larissa N. Niemeijer, Aniko V. Fejes, Lee-Ann Tjon Kon Fat, Anna E. Huis in ‘t Veld, Cyra E Leurs, Tessa Y. Le Large, Laura L. Meijer, Irsan Kooi, François Rustenburg, Pepijn Schellen, Heleen Verschueren, Edward P. Post, Laurine E. Wedekind, Jillian Wilhelmina Paulina Bracht, Michelle Esenkbrink, Leon J. Wils, Francesca Favaro, Jilian D. Schoonhoven, Jihane Tannous, Hanne Meijers‐Heijboer, Geert Kazemier, Elisa Giovannetti, Jaap C. Reijneveld, Sander Idema, Joep Killestein, Michal Heger, Saskia C.A. de Jager, Rolf T. Urbanus, Imo E. Hoefer, Gerard Pasterkamp, Christine Mannhalter, Jose Gomez‐Arroyo, Harm Jan Bogaard, David P. Noske, W. Peter Vandertop, Daan van den Broek, Bauke Ylstra, R. Jonas A. Nilsson, Pieter Wesseling, Niki Karachaliou, Rafael Rosell, Elizabeth Lee-Lewandrowski, Kent Lewandrowski, Bakhos A. Tannous, Adrianus J. de Langen, Egbert F. Smit, Michel M. van den Heuvel, Thomas Würdinger - Cancer Cell 2017 被引用: 333

  15. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    著者: Nasser H. Hanna, Andrew Robinson, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Laurie E. Gaspar, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, Ishmael Jaiyesimi, David H. Johnson, Natasha B. Leighl, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, Navneet Singh, David R. Spigel, Joan Tashbar, Gregory A. Masters - Journal of Clinical Oncology 2021 被引用: 301

  16. Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutations

    著者: Tony Mok, Ying Cheng, Xiangdong Zhou, Ki Hyeong Lee, Kazuhiko Nakagawa, Seiji Niho, Min Lee, R. Linke, Rafael Rosell, J. Corral, Maria Rita Migliorino, Adam Płużański, Eric Sbar, Tao Wang, Jane Liang White, Yi‐Long Wu - Journal of Clinical Oncology 2018 被引用: 436

  17. Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study

    著者: Shirish M. Gadgeel, Solange Peters, Tony Mok, Alice T. Shaw, D.W. Kim, Sai‐Hong Ignatius Ou, M. Pérol, Anna Wrona, Silvia Novello, Rafael Rosell, Ali Zeaiter, Tian Liu, Eveline Nüesch, Bogdan Balas, D. Ross Camidge - Annals of Oncology 2018 被引用: 324

  18. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

    著者: Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory A. Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael Jaiyesimi - Journal of Clinical Oncology 2022 被引用: 124

  19. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline

    著者: Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory A. Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael Jaiyesimi - Journal of Clinical Oncology 2022 被引用: 113

  20. Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer

    著者: Élisabeth Brambilla, Gwénaël Le Teuff, Sophie Marguet, Sylvie Lantuéjoul, Ariane Dunant, Stephen L. Graziano, Robert Pirker, Jean-Yves Douillard, Thierry Le Chevalier, Martin Filipits, Rafael Rosell, Robert A. Kratzke, Helmut Popper, Jean‐Charles Soria, Frances A. Shepherd, Lesley Seymour, Ming‐Sound Tsao - Journal of Clinical Oncology 2016 被引用: 361

  21. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

    著者: Jean‐Yves Douillard, Rafael Rosell, Mario De Lena, Francesco Carpagnano, Rodryg Ramlau, Jose Luis Gonzáles-Larriba, Tomasz Grodzki, José Rodrigues Pereira, A. Le Groumellec, Vito Lorusso, C. Clary, Antonio J. Torres, Jabrail Dahabreh, Pierre‐Jean Souquet, Julio Astudillo, P. Fournel, Á. Artal, Jacek Jassem, Leona Koubková, Patricia His, M Riggi, P Hurteloup - The Lancet Oncology 2006 被引用: 1,588

  22. Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort

    著者: Julien Mazières, Fabrice Barlési, Thomas Filleron, Benjamin Besse, I. Monnet, Michèle Beau‐Faller, Solange Peters, Éric Dansin, Martin Früh, Miklos Pless, Rafael Rosell, Marie Wislez, P. Fournel, Virginie Westeel, Federico Cappuzzo, Alexis B. Cortot, Denis Moro‐Sibilot, Julie Milia, Oliver Gautschi - Annals of Oncology 2015 被引用: 330

  23. Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer

    著者: Enriqueta Felip, Rafael Rosell, J Maestre, José Manuel Rodríguez-Paniagua, Teresa Morán, Julio Astudillo, Guillermo Alonso, José Manuel Borro, J.L. González-Larriba, Antonio Torres, Carlos Camps, R. Guijarro, Dolores Isla, Rafael Aguiló, Vicente Alberola, José Padilla, Abel Sánchez‐Palencia, José Javier Sánchez, Eduardo Hermosilla, Bartomeu Massutí - Journal of Clinical Oncology 2010 被引用: 430

  24. Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non–Small Cell Lung Cancer

    著者: Óscar Arrieta, Feliciano Barrón, Laura Alejandra Ramírez-Tirado, Zyanya Lucía Zatarain-Barrón, Andrés F. Cardona, Diego A. Díaz-García, Masao Yamamoto Ramos, Beatriz Mota-Vega, Amir Carmona, Marco Polo Peralta Álvarez, Yolanda Bautista, Fernando Aldaco, Raquel Gerson, Christian Rolfo, Rafael Rosell - JAMA Oncology 2020 被引用: 153